Dynamics of ARF regulation that control senescence and cancer

키워드

참고문헌 (87)

1. Kim WY, "The regulation of INK4", ARF in cancer and aging, 2006, pp.127, 265~275
2. Gil J, "Regulation of the INK4b-ARFINK4a tumour suppressor locus: all for one or one for all", Nat Rev Mol Cell Biol, 7, pp.667~677 (2006)
3. Haupt Y, "Mdm2promotes the rapid degradation of p53", Nature, 387, pp.296~299 (1997)
4. Pomerantz J, "The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53", Cell, 92, pp.713~723 (1998)
5. Kamijo T, "Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2", Proc Natl Acad Sci U S A, 95, pp.8292~8297 (1998)
6. Weber JD, "Nucleolar Arf sequesters Mdm2 and activates p53", Nat Cell Biol, 1, pp.20~26 (1999)
7. Chen D, "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", Nature, 464, pp.624~627 (2010)
8. Ko A, "Acceleration of gastric tumorigenesis through MKRN1-mediated posttranslational regulation of p14ARF", J Natl Cancer Inst, 104, pp.1660~1672 (2012)
9. Wang X, "Siva1 inhibits p53function by acting as an ARF E3 ubiquitin ligase", Nat Commun, 4, pp.1551~ (2013)
10. DeGregori J, "Distinct roles for E2F proteins in cell growth control and apoptosis", Proc Natl Acad Sci U S A, 94, pp.7245~7250 (1997)
11. Aslanian A, "Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics", Genes Dev, 18, pp.1413~1422 (2004)
12. Schmitt CA, "Senescence, apoptosis and therapy--cutting the lifelines of cancer", Nat Rev Cancer, 3, pp.286~295 (2003)
13. Zindy F, "Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization", Genes Dev, 12, pp.2424~2433 (1998)
14. Bouchard C, "FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf", Genes Dev, 21, pp.2775~2787 (2007)
15. Inoue K, "Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1", Proc Natl Acad Sci U S A, 96, pp.3993~3998 (1999)
16. Linggi B, "The t(8;21)fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF)tumor suppressor in acute myeloid leukemia", Nat Med, 8, pp.743~750 (2002)
17. Sreeramaneni R, "Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor", Mol Cell Biol, 25, pp.220~232 (2005)
18. Zheng Y, "Tgfβ signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2", 3 and p38 MAPK, 2010, pp.285, 35654~35664
19. Bulavin DV, "Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf)pathway", Nat Genet, 36, pp.343~350 (2004)
20. Yoon JH, "Human Kruppelrelated 3(HKR3)is a novel transcription activator of alternate reading frame(ARF)gene", J Biol Chem, 289, pp.4018~4031 (2014)
21. Jacobs JJ, "The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus", Nature, 397, pp.164~168 (1999)
22. Bracken AP, "The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells", Genes Dev, 21, pp.525~530 (2007)
23. Gil J, "Polycomb CBX7 has a unifying role in cellular lifespan", Nat Cell Biol, 6, pp.67~72 (2004)
24. Jacobs JJ, "Senescence bypass screen identifies TBX2, which represses Cdkn2a(p19(ARF))and is amplified in a subset of human breast cancers", Nat Genet, 26, pp.291~299 (2000)
25. Cakouros D, "Twist-1induces Ezh2 recruitment regulating histone methylation along the Ink4A", Arf locus in mesenchymal stem cells, 2012, pp.32, 1433~1441
26. Kuo ML, "N-terminal polyubiquitination and degradation of the Arf tumor suppressor", Genes Dev, 18, pp.1862~1874 (2004)
27. Eischen CM, "Disruption of the ARF-Mdm2-p53tumor suppressor pathway in Myc-induced lymphomagenesis", Genes Dev, 13, pp.2658~2669 (1999)
28. Wang Y, "Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin", Oncogene, 18, pp.2643~2649 (1999)
29. Chang BD, "Role of p53and p21waf1", cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs, 1999, pp.18, 4808~4818
30. Moore L, "Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis", Oncogene, 22, pp.7831~7837 (2003)
31. Weber JD, "p53-independent functions of the p19(ARF)tumor suppressor", Genes Dev, 14, pp.2358~2365 (2000)
32. Ha L, "ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence", Proc Natl Acad Sci U S A, 104, pp.10968~10973 (2007)
33. Eymin B, "Human ARF binds E2F1 and inhibits its transcriptional activity", Oncogene, 20, pp.1033~1041 (2001)
34. Tsuji K, "p53-independent apoptosis is induced by the p19ARF tumor suppressor", Biochem Biophys Res Commun, 295, pp.621~629 (2002)
35. Yarbrough WG, "Human tumor suppressor ARF impedes S-phase progression independent of p53", Cancer Res, 62, pp.1171~1177 (2002)
36. Hemmati PG, "Adenovirus-mediated overexpression of p14(ARF)induces p53 and Bax-independent apoptosis", Oncogene, 21, pp.3149~3161 (2002)
37. Eymin B, "p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice", Oncogene, 22, pp.1822~1835 (2003)
38. Kelly-Spratt KS, "p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and-independent pathways", PLoS Biol, 2, pp.E242~ (2004)
39. Leduc C, "p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation", Oncogene, 25, pp.4147~4154 (2006)
40. Itahana K, "Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation", Mol Cell, 12, pp.1151~1164 (2003)
41. Brady SN, "ARF impedes NPM", B23 shuttling in an Mdm2-sensitive tumor suppressor pathway, 2004, pp.24, 9327~9338
42. Fatyol K, "The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha(HIF-1alpha)and inhibits HIF-1-mediated transcription", J Biol Chem, 276, pp.28421~28429 (2001)
43. Kalinichenko VV, "Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor", Genes Dev, 18, pp.830~850 (2004)
44. Qi Y, "p19ARF directly and differentially controls the functions of c-Myc independently of p53", Nature, 431, pp.712~717 (2004)
45. Amente S, "p14ARF interacts with N-Myc and inhibits its transcriptional activity", FEBS Lett, 581, pp.821~825 (2007)
46. Rocha S, "Regulation of NF-kappaB and p53through activation of ATR and Chk1 by the ARF tumour suppressor", EMBO J, 24, pp.1157~1169 (2005)
47. Paliwal S, "Targeting of C-terminal binding protein(CtBP)by ARF results in p53-independent apoptosis", Mol Cell Biol, 26, pp.2360~2372 (2006)
48. Xirodimas DP, "P14ARF promotes accumulation of SUMO-1conjugated(H)Mdm2", FEBS Lett, 528, pp.207~211 (2002)
49. Chen L, "MDM2-ARF complex regulates p53 sumoylation", Oncogene, 22, pp.5348~5357 (2003)
50. Woods YL, "p14 Arf promotes small ubiquitinlike modifier conjugation of Werners helicase", J Biol Chem, 279, pp.50157~50166 (2004)
51. Rizos H, "p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners", Cell Cycle, 4, pp.597~603 (2005)
52. Tago K, "Sumoylation induced by the Arf tumor suppressor: a p53-independent function", Proc Natl Acad Sci U S A, 102, pp.7689~7694 (2005)
53. Damalas A, "Loss of p14(ARF)confers resistance to heat shock-and oxidative stress-mediated cell death by upregulating beta-catenin", Int J Cancer, 128, pp.1989~1995 (2011)
54. Pan W, "P19ARF inhibits the functions of the HPV16 E7oncoprotein", Oncogene, 22, pp.5496~5503 (2003)
55. Serrano M, "Role of the INK4a locus in tumor suppression and cell mortality", Cell, 85, pp.27~37 (1996)
56. Kamijo T, "Tumor spectrum in ARF-deficient mice", Cancer Res, 59, pp.2217~2222 (1999)
57. Sharpless NE, "The differential impact of p16(INK4a)or p19(ARF)deficiency on cell growth and tumorigenesis", Oncogene, 23, pp.379~385 (2004)
58. Kamijo T, "Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF", Cell, 91, pp.649~659 (1997)
59. Sharpless NE, "Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis", Nature, 413, pp.86~91 (2001)
60. Jacobs JJ, "Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a", ARF, 1999, pp.13, 2678~2690
61. Schmitt CA, "INK4a", ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53, 1999, pp.13, 2670~2677
62. Chin L, "Cooperative effects of INK4a and ras in melanoma susceptibility in vivo", Genes Dev, 11, pp.2822~2834 (1997)
63. Matheu A, "Increased gene dosage of Ink4a", Arf results in cancer resistance and normal aging, 2004, pp.18, 2736~2746
64. Shintani S, "Inactivation of the p14(ARF), p15(INK4B)and p16(INK4A)genes is a frequent event in human oral squamous cell carcinomas", Oral Oncol, 37, pp.498~504 (2001)
65. Konishi N, "Heterogeneous methylation and deletion patterns of the INK4a", ARF locus within prostate carcinomas, 2002, pp.160, 1207~1214
66. Sailasree R, "Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma", Cancer Epidemiol Biomarkers Prev, 17, pp.414~420 (2008)
67. Ito T, "Alteration of the p14(ARF)gene and p53status in human hepatocellular carcinomas", J Gastroenterol, 39, pp.355~361 (2004)
68. Berggren P, "Detecting homozygous deletions in the CDKN2A(p16(INK4a))", ARF(p14(ARF))gene in urinary bladder cancer using real-time quantitative PCR, 2003, pp.9, 235~242
69. Hsu HS, "5' cytosinephospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53overexpression in resected non-small cell lung cancer", Clin Cancer Res, 10, pp.4734~4741 (2004)
70. Silva J, "Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms", J Pathol, 199, pp.289~297 (2003)
71. Silva J, "Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer", Oncogene, 20, pp.4586~4590 (2001)
72. Dominguez G, "p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients", Clin Cancer Res, 8, pp.980~985 (2002)
73. Dominguez G, "Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors", Mutat Res, 530, pp.9~17 (2003)
74. Lee M, "Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer", Pathol Res Pract, 202, pp.415~424 (2006)
75. Esteller M, "Hypermethylation-associated inactivation of p14(ARF)is independent of p16(INK4a)methylation and p53 mutational status", Cancer Res, 60, pp.129~133 (2000)
76. Tannapfel A, "Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma", J Pathol, 197, pp.624~631 (2002)
77. Tannapfel A, "INK4a-ARF alterations in liver cell adenoma", Gut, 51, pp.253~258 (2002)
78. Iida S, "Alterations and hypermethylation of the p14(ARF)gene in gastric cancer", Int J Cancer, 87, pp.654~658 (2000)
79. Zochbauer-Muller S, "Aberrant promoter methylation of multiple genes in non-small cell lung cancers", Cancer Res, 61, pp.249~255 (2001)
80. Chaar I, "Biological significance of promoter hypermethylation of p14", ARF gene: relationships to p53 mutational status in Tunisian population with colorectal carcinoma, 2014, pp.35, 1439~1449
81. Kasahara T, "Homozygous deletions of the INK4a", ARF locus in renal cell cancer, 2006, pp.26, 4299~4305
82. Inda MM, "High promoter hypermethylation frequency of p14", ARF in supratentorial PNET but not in medulloblastoma, 2006, pp.48, 579~587
83. Rizos H, "Mutations in the INK4a", ARF melanoma susceptibility locus functionally impair p14ARF, 2001, pp.276, 41424~41434
84. Rizos H, "A melanomaassociated germline mutation in exon 1beta inactivates p14ARF", Oncogene, 20, pp.5543~5547 (2001)
85. Hewitt C, "Germline mutation of ARF in a melanoma kindred", Hum Mol Genet, 11, pp.1273~1279 (2002)
86. Randerson-Moor JA, "A germline deletion of p14(ARF)but not CDKN2A in a melanoma-neural system tumour syndrome family", Hum Mol Genet, 10, pp.55~62 (2001)
87. Gazzeri S, "The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer", Cancer Res, 58, pp.3926~3931 (1998)

관련 논문AI추천